-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

625.O2.6 625. T Cell, NK Cell, or NK/T Cell Lymphomas: Clinical and Epidemiological: Are We Ready to Move the Needle in T Cell Lymphomas?

Symposia: T Cell, NK Cell, or NK/T Cell Lymphomas: Clinical and Epidemiological Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Lymphoid Leukemias, Research, Clinical trials, Combination therapy, Adult, Antibody Therapy, Drug development, Lymphomas, Epidemiology, Clinical Research, LGL, Health outcomes research, T Cell lymphoma, Diseases, Therapy sequence, Treatment Considerations, Biological therapies, Aggressive lymphoma, Real-world evidence, Lymphoid Malignancies, Monoclonal Antibody Therapy, Study Population, Human
Monday, December 9, 2024: 4:30 PM-6:00 PM
Pacific Ballroom Salons 15-17 (Marriott Marquis San Diego Marina)
Moderators:
N. Nora Bennani, MD, Mayo Clinic and Tarsheen Sethi, MD, MSc, Yale University School of Medicine
Disclosures:
Bennani: Acrotech Biopharma LLC: Membership on an entity's Board of Directors or advisory committees, Other: Advisory board; Pfizer: Membership on an entity's Board of Directors or advisory committees. Sethi: MERCK: Research Funding.
4:30 PM

Thierry Lamy, MD, PhD1,2*, Cedric Pastoret, MD PhD3*, Gandhi Damaj, MD, PhD4,5*, Olivier Tournilhac6,7*, Emmanuel Bachy, MD, PhD8, Loic Ysebaert, MD, PhD9*, Frederique Orsini Piocelle, MD10*, Anne Banos, MD11*, Marianne Schwarz, MD12*, Estibaliz Lazaro, MD13*, Pierre Feugier, MD, PhD14*, Hugo Gonzalez, MD15*, Alain Renault16*, Milena Kohn, MD17*, Roch Houot, MD, PhD18*, Mikael Roussel, MD, PhD19* and Eric Bellissant, MD PhD20*

1Hospital Pontchaillou, Rennes, AL, France
2Pontchaillou Hospital Rennes UNIVERSITY HOSPITAL, Rennes, France
3Rennes University Hospital, RENNES, FRA
4CHU Caen, Caen, Normandy, FRA
5Hematology Institute, University Of Caen Normandie Hospital Center, Caen, France
6CHU de Clermont-Ferrand, CLERMONT FERRAND, AURA, FRA
7CHU Estaing, Clermont-Ferrand University Hospital, CLERMONT FERRAND, AURA, France
8Lyon Sud Hospital, Lyon, France
9Hematology Department, Institut Universitaire du Cancer Toulouse Oncopole, Toulouse, France
10hematology, ANNECY Hospital, annecy, France
11Centre Hospitalier De Bayonne, Bayonne, FRA
12Centre Hospitalier Universitaire d’Angers, Angers, France
13Internal medicine, Bordeaux University Hospital, Bordeaux, France
14CHU Brabois - Service d'Hématologie - Université Henri Poincaré, Nancy, France
15Hematology, Pontoise Hospital, pontoise, France
16Clinica lresearch department, Rennes University Hospital, Rennes, France
17Versailles Hospital, Le Chesnay, FRA
18Rennes university hospital - Hospital Pontchaillou, Rennes, France
19Laboratory of Hematology and Flow cytometry, CHU Rennes, Rennes, France
20Rennes University Hospital, Rennes, France

4:45 PM

Jasmine Zain, MD1, Swaminathan P Iyer, MD2*, Enrica Marchi, MD, PhD3, Mitul Gandhi, MD4, Youn H. Kim, MD5, Michael S. Khodadoust, MD, PhD6, Jonathan E. Brammer7, Christina Poh, MD8, Pierluigi Porcu9, Kimberley Dilley, MD, MPH10*, Matthias Will, MD10, Andrea Kantor10*, Cathrine Leonowens, PhD10*, Nenad Tomasevic, PhD10*, H. Miles Prince, MD, MBBS11 and Steven Horwitz, MD12

1City of Hope, Duarte, CA
2University of Texas MD Anderson Cancer Center, Houston, TX
3University of Virgina Comprehensive Cancer Center, Charlottesville, VA
4Next Oncology, Fairfax, VA
5Stanford Cancer Center, Stanford, CA
6Stanford Cancer Center, Palo Alto, CA
7The Ohio State University Comprehensive Cancer Center, Columbus, OH
8Fred Hutchinson Cancer Center, Seattle, WA
9Jefferson Health, Philadelphia, PA
10Dren Bio, Inc, Foster City, CA
11Epworth HealthCare and University of Melbourne, Melbourne, VIC, Australia
12Memorial Sloan Kettering Cancer Center, New York, NY

5:00 PM

Madeline A. Jenkin, BS1*, Daniel Antonio, BS, MPH1* and Jonathan Moreira, MD2

1Northwestern University Feinberg School of Medicine, Chicago
2Robert H Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL

5:15 PM

Zachary Braunstein, MD1, Eric McLaughlin, MS2*, Prasanth Lingamaneni, MBBS3, Stefan K. Barta, MD4, Miao Cao, BS5*, Tiffany Chang, MS6*, Nivetha Ganesan, MPH6*, Binh Luu, BS7*, Neha Mehta-Shah, MD8, Tanaya Shree, MD, PhD9, Marcus P. Watkins, PhD10*, Jasmine Zain, MD11, Pamela B. Allen, MD12, Darina Paulino, MS13*, Brittany Adams13*, Jie Wang, MD, MS14, Amber Feng, MD15*, Enrica Marchi, MD, PhD16, Nathan Roberts, MD17, Ryan A. Wilcox, MD, PhD18, Marc Gabriel Gutierrez, MD19*, Zachary AK Frosch, MD, MSHP20, Tammarah Sklarz, MD21, Tarsheen Sethi, MD, MSc22, Francine M. Foss, MD23, Anne W Beaven, MD24, Bradley M. Haverkos, MD, MS, MPH25, Rachel Treitman, BS26*, Patrick Stevens, MS27*, Anjali Mishra28, Robert Stuver, MD29, Paul J Hampel, MD3 and Jonathan E. Brammer30

1The James Cancer Hospital at The Ohio State University Wexner Medical Center, Columbus, OH
2Center for Biostatistics, The Ohio State University, Columbus, OH
3Division of Hematology, Mayo Clinic, Rochester, MN
4Division of Hematology-Oncology, Perelman Center for Advanced Medicine, University of Pennsylvania, Philadelphia, PA
5Department of Medicine, Division of Hematology/Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA
6Memorial Sloan Kettering Cancer Center, New York, NY
7Knight Cancer Institute, Oregon Health & Science University, Portland, OR
8Siteman Cancer Center, Washington University in St. Louis, St Louis, MO
9Knight Cancer Institute, Oregon Health and Sciences University, Portland, OR
10Division of Oncology, Washington University School of Medicine, St. Louis, MO
11City of Hope, Duarte, CA
12Department of Hematology, Emory University School of Medicine, Decatur, GA
13Department of Hematology and Oncology, Winship Cancer Institute of Emory University, Atlanta, GA
14Duke Cancer Institute, Hillsborough, NC
15Division of Hematologic Malignancies and Cellular Therapies, Duke Cancer Institute, Durham, NC
16Division of Hematology and Oncology, Department of Medicine, University of Virginia Health System, Charlottesville, VA
17University of Virginia, Charlottesville, VA
18Division of Hematology/Oncology, University of Michigan, Ann Arbor, MI
19Division of Hematology/Oncology, University of Michigan Cancer Center, Ann Arbor, MI
20Department of Hematology/Oncology; Cancer Prevention and Control Research Program, Fox Chase Cancer Center, Philadelphia, PA
21Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, PA
22Hematology, Yale University School of Medicine, New Haven, CT
23Yale University School of Medicine, Hamden, CT
24Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC
25Division of Hematology, University of Colorado School of Medicine, Aurora, CO
26University of Colorado School of Medicine, Denver, CO
27Department of Biomedical Informatics, The Ohio State University, Columbus, OH
28Thomas Jefferson University, Sydney Kimmel Cancer Center, Philadelphia, PA
29Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
30Division of Hematology, The Ohio State University, Columbus, OH

5:30 PM

Carolina Romero, MD1*, Macarena Roa, MD2*, Henry Idrobo, MD3*, Denisse Castro, MD4, Brady E Beltran, MD5,6*, Daniel J Enriquez, MD7*, Jule F Vasquez, MD8, Claudia Roche, MD9*, Daniel Artiles, MD10*, Fabiola Valvert, MD, FRCP11, Luis Mario Villela Martinez, MD, MSc12*, Juliana Pereira, MD, PhD13, Ana Carolina Oliver, MD14, Jamila Vaz Tavarez, MD15*, Sergio Augusto B Brasil, MD, PhD16*, Karin Z Cecyn, MD17*, Nelson S Castro, MD18*, Renata Lyrio R Baptista, MD19,20*, Samuel S. Medina, MD21*, Davimar Miranda Maciel Borducchi, PhD22, Marcelo Bellesso, MD23*, Danielle Leão Cordeiro De Farias, MD, MSc, MBA24, Yung Gonzaga, MD25*, Laura Korin, MD26*, Patricio Pereyra, PhD27*, Camila Peña, MD2, Maria Alejandra Torres Viera, MD28*, Kelly Meza, MD29*, Seisha Von Glasenapp, PhD30, Alfredo Quiroz, MD31*, Cesar Samanez-Figari, MD32*, Rosa Oliday Rios Jimenez33*, Sally Paredes, MD4*, Thais Fischer, MD34*, Asaad Trabolsi, MD35, Jonathan H. Schatz, MD36, Swaminathan P Iyer, MD37*, Ranjit Nair, MD38, Eduardo Edelman Saul, MD39, Casey Bermack, MD37, Jorge J. Castillo, MD40, Carmino De Souza, MD, PhD41*, Eliana Miranda, PhD, MEd41*, Bryan Valcarcel, MD, MPH42, Carlos Chiattone, MD, PhD16,43 and Luis Enrique Malpica Castillo, MD44

1Hospital del Salvador, Santiago, Chile
2Hospital Del Salvador, Santiago, Chile
3Universidad del Valle del Cauca, Cali, COL
4Hospital Edgardo Rebagliati Martins, Lima, Peru
5Servicio Oncología Médica, Hospital Edgardo Rebagliati, Lima, Peru
6Instituto de Investigación en Ciencias Biomédicas, Universidad Ricardo Palma, Lima, Peru
7Instituto Nacional De Enfermedades Neoplasicas, Lima, Peru
8Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru
9Hospital Armando Milan Castro, Vila Clara, Cuba
10Hospital Arnoldo Milan Castro, Vila Clara, Cuba
11INCAN, Ciudad de Guatemala, Guatemala
12Hospital Fernando Ocaranza, Hermosillo, Mexico
13University of São Paulo, Department of Hematology, Hemotherapy & Cell Therapy, University of São Paulo, São Paulo, São Paulo, Brazil
14Hospital Britanico de Montevideo, Montevideo, Uruguay
15Ophir Loyola Hospital, Belém, Brazil
16Santa Casa Medical School of Sao Paulo, Sao Paulo, Brazil
17Federal University of Sao Paulo, Sao Paulo, Brazil
18Hospital de Cancer de Barretos, Barretos, São Paulo, BRA
19Instituto D'Or de Pesquisa e Ensino, Rio de Janeiro, Brazil
20State University of Rio de Janeiro, Rio De Janeiro, Brazil
21University of Campinas, São Paulo, BRA
22Medical School of ABC, Santo Andre, Brazil
23HemoMed, Instituto de Ensino e Pesquisa – IEP, Sao Paulo, Brazil
24Beneficencia Portuguesa Hospital, Sao Paulo, Brazil
25Cancer National Institute, Rio De Janeiro, Brazil
26CABA- Alexander Fleming Institute, Olivos, Argentina
27Hospital Nacional Posadas, Buenos Aires, Argentina
28Clinica Santa Sofia, Caracas, Venezuela (Bolivarian Republic of)
29Baylor College of Medicine, Houston, TX
30Hospital Central Instituto de Previsión Social, Asuncion, Paraguay
31Departamento de Hematología, Hospital Central Instituto de Previsión Social, Asunción, Paraguay
32Oncosalud, AUNA, Lima, Peru
33Hospital Clínico Quirúrgico Hermanos Amejeiras, La Habana, Cuba
34Santa Casa de São Paulo Medical School, São Paulo, Brazil
35University of Miami, Sylvester Comprehensive Cancer Center, Miami, FL
36Department of Hematology, University of Miami, Sylvester Comprehensive Cancer Center, Miami, FL
37University of Texas MD Anderson Cancer Center, Houston, TX
38University of Texas MD Anderson Cancer Center, Pearland, TX
39Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
40Dana-Farber Cancer Institute, Bing Center for Waldenström Macroglobulinemia, Boston, MA
41Centro de Hematologia e Hemoterapia (HEMOCENTRO), Universidade Estadual de Campinas (UNICAMP), Campinas, Brazil
42George Washington University, Washington, DC
43Hospital Samaritano-Higienopolis, Sao Paulo, Brazil
44Department of Lymphoma and Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX

5:45 PM

Max J Gordon, MD1*, Milos D Miljkovic, MD2, Samuel Ng, MD, PhD3, Rahul Lakhotia, MBBS1, Christopher Melani, MD4, Kevin Conlon3*, James D. Phelan, PhD1*, Bonita Bryant1*, Laura M Yee5*, Stefania Pittaluga, MD, PhD6*, Elaine S. Jaffe, MD7, Louis M. Staudt, MD, PhD8, Wyndham H. Wilson, MD, PhD1* and Mark Roschewski, MD3

1Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD
2Cartesian Therapeutics, Inc., Frederick, MD
3National Cancer Institute, Bethesda, MD
4Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Derwood, MD
5Office of Collaborative Biostatistics, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD
6Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD
7Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Great Falls, VA
8Metabolism Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD

*signifies non-member of ASH